Company Filing History:
Years Active: 1995-2014
Title: Yu-Der Lee: Innovator in Nanoparticle Technology
Introduction
Yu-Der Lee is a prominent inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of nanoparticle technology, particularly in the development of drug delivery systems. With a total of 4 patents to his name, Lee's work has the potential to impact various therapeutic applications.
Latest Patents
One of Yu-Der Lee's latest patents is focused on drug-loaded poly (alkyl-cyanoacrylate) nanoparticles and the process for their preparation. This innovative process describes how to synthesize cyanoacrylate nanoparticles that effectively deliver biological and therapeutic agents through miniemulsion polymerization using surfactants like pluronic F127 or F68. The method allows for the dissolution of highly hydrophobic active agents in cyanoacrylate monomers before polymerization, resulting in nanoparticles with higher loading and encapsulation efficiencies compared to those produced by traditional emulsion polymerization.
Another notable patent involves the preparation of a laminated composite of condensation type silicone rubber and polyurethane by inducing surface reconstruction. This advancement showcases Lee's versatility and expertise in materials science.
Career Highlights
Throughout his career, Yu-Der Lee has worked with esteemed organizations such as the Chung Shan Institute of Science and Technology and the Industrial Technology Research Institute. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research in his field.
Collaborations
Yu-Der Lee has collaborated with notable colleagues, including Ming-Fu Tsai and Wen-Hsiung Ku. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
In summary, Yu-Der Lee is a distinguished inventor whose work in nanoparticle technology is paving the way for advancements in drug delivery systems. His innovative patents and collaborations highlight his commitment to improving therapeutic applications through scientific research.